| Heading: |
Gender Dysphoria: Puberty Suppressing Hormones |
| Question ID: |
1757192 |
| UIN: |
25257 |
| House: |
Commons |
| Date tabled: |
2025-01-21 |
| Asking Member ID: |
4436 |
| Asking Member display name: |
Cat Smith
|
| Asking Member handle: |
CatSmithMP
|
| Asking Member Twitter reference: |
@CatSmithMP
|
| Member interest: |
false |
| Question text: |
To ask the Secretary of State for Health and Social Care, if he will make an assessment of the impact of the restriction of puberty blockers for the treatment of gender incongruence on the (a) physical and (b) mental health of young trans people. |
| Is named day: |
false |
| Date of holding answer: |
|
| Date answered: |
2025-01-29 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
4444 |
| Answering Member display name: |
Karin Smyth
|
| Answering Member handle: |
karinsmyth
|
| Answering Member Twitter reference: |
@karinsmyth
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
On 11 December 2024 the Government introduced The Medicines (Gonadotrophin-Releasing Hormone Analogues) (Restrictions on Private Sales and Supplies) Order 2024, which came into effect on 1 January 2025. Alongside this legislation the Government published ... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |